Minerva Neurosciences, Inc. - 8-K Filing
Minerva Neurosciences issues revised KOL event transcript to clarify regulatory statements regarding roluperidone. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $NERV
Read the full article at SEC EDGAR
Part of the story Nkarta, Inc. - 8-K Filing (3 articles)